Annual report pursuant to Section 13 and 15(d)

Stock-Based Compensation (Tables)

v3.21.1
Stock-Based Compensation (Tables)
12 Months Ended
Mar. 31, 2021
Stock-Based Compensation  
Summary of stock-based compensation expense by statement of operations line item

The following table summarizes, by consolidated statements of operations line item, stock-based compensation expense (in thousands):

 

 

 

 

 

 

 

 

 

 

Year Ended March 31,

 

 

    

2021

    

2020

 

Cost of goods sold

 

$

83

    

$

69

 

Research and development

 

 

41

 

 

44

 

Selling, general and administrative

 

 

813

 

 

800

 

Stock-based compensation expense

 

$

937

 

$

913

 

 

Summary of stock option activity

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted-

 

 

 

 

 

 

 

 

 

 

Average

 

 

 

 

 

 

 

Weighted-

 

Remaining

 

Aggregate

 

 

 

 

 

Average

 

Contractual

 

Intrinsic

 

 

 

Shares

 

Exercise Price

 

Term

 

Value

 

 

 

 

 

 

 

 

(in years)

 

 

 

 

Options outstanding at March 31, 2020

    

11,249

    

$

215.56

    

 

    

 

 

 

Granted

 

 —

 

$

 —

 

 

 

 

 

 

Exercised

 

 —

 

$

 —

 

 

 

 

 

 

Forfeited, cancelled or expired

 

(2,325)

 

$

204.97

 

 

 

 

 

 

Options outstanding at March 31, 2021

 

8,924

 

$

218.32

 

1.6

 

 

 —

 

Options fully vested at March 31, 2021 and those expected to vest beyond March 31, 2021

 

8,924

 

$

218.32

 

1.6

 

 

 —

 

Options exercisable at March 31, 2021

 

8,924

 

$

218.32

 

1.6

 

 

 —

 

 

Summary of restricted stock activity

 

 

 

 

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

Average Grant

 

 

 

 

 

Date Fair

 

Restricted Stock Units and Performance Restricted Stock Units

 

Shares

 

Value

 

Non-vested restricted stock units outstanding at March 31, 2020

    

330,830

    

$

6.28

 

Granted

 

308,503

 

 

5.28

 

Vested and issued

 

(128,865)

 

 

6.44

 

Forfeited

 

(13,187)

 

 

5.21

 

Non-vested restricted stock units outstanding at March 31, 2021

 

497,281

 

 

5.65

 

Restricted stock units expected to vest beyond March 31, 2021

 

497,281

 

$

5.65

 

 


 

 

 

 

 

 

 

 

 

 

 

Year Ended March 31,

 

    

    

2021

    

2020

Restricted stock compensation expense (in thousands)

 

    

$

937

    

$

913

Aggregate fair value of restricted stock units vested and issued (in thousands)

 

    

$

352

    

$

384

Weighted average grant date fair value of restricted stock units granted during the period

 

    

$

5.28

    

$

4.74

 

Schedule of fair value assumptions - warrants

 

 

 

 

    

Year Ended

 

    

March 31, 2021

Risk-free interest rate

 

0.2%

Contractual term

 

3 years

Expected volatility

 

81.0%